ArticleFrontiers in pharmacology2025
Health risks of cocaine adulteration: local anesthetics as modulators of monoamine and organic cation transporters.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Local anesthetics (LAs) are frequently used as adulterants in cocaine sold on the illicit market, sometimes in higher quantities than cocaine itself. These agents can mimic cocaine's anesthetic effect, masking the products reduced purity. While reports suggest that LAs influence monoaminergic neurotransmission, systematic evidence remains limited. We examined three LAs commonly detected in cocaine samples submitted for drug checking from Vienna, Austriaprocaine, benzocaine, and lidocainefor their activity on uptake-1 monoamine transporters (DAT, NET, SERT) and uptake-2 organic cation transporters (OCT13). Methods and Results: Transporter activity was measured in vitro, and computational docking was applied to explore molecular interactions with atomistic detail. Procaine and benzocaine inhibited DAT and NET at physiologically relevant concentrations, whereas neither compound affected SERT. Procaine also inhibited OCT1 and OCT2 with affinities comparable to or greater than cocaine, while benzocaine exhibited no OCT activity. Lidocaine had no significant effect on any transporter. Docking studies confirmed procaine binding within the DAT substrate pocket, consistent with its inhibitory profile. Discussion: Although LAs modulate uptake-1 and uptake-2 transporters, their actions are insufficient to replicate cocaine's psychoactive effects. However, their impact on OCTs indicates potential health risks, highlighting the importance of accessible drug checking services for harm reduction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.